Automated Anesthesia During Bronchoscopy
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to compare manual administration of propofol and remifentanil and dual closed-loop using bispectral index as the control variable during rigid bronchoscopy.
| Condition | Intervention | Phase |
|---|---|---|
|
Anesthesia, General |
Device: Closed-loop system Device: TCI (Infusion Toolbox) |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Target-Controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by the Index Bispectral: Comparison Between Manual Perfusion and Automated Perfusion During Rigid Bronchoscopy |
- Percentage of time with BIS in the desired range [ Time Frame: During the procedure ] [ Designated as safety issue: No ]
- consumption of propofol and remifentanil [ Time Frame: during the procedure ] [ Designated as safety issue: No ]
- extubation time [ Time Frame: during the procedure ] [ Designated as safety issue: No ]
- explicit memorisation [ Time Frame: postoperative day 2 ] [ Designated as safety issue: Yes ]
| Enrollment: | 66 |
| Study Start Date: | December 2007 |
| Study Completion Date: | September 2008 |
| Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 |
Device: Closed-loop system
Automatic delivery of propofol and remifentanil
|
| Active Comparator: 2 |
Device: TCI (Infusion Toolbox)
TCI administration of propofol and remifentanil
|
Detailed Description:
The Bispectral Index (BIS) is an electroencephalogram-derived measure of anesthetic depth. We have built a combined closed-loop anesthesia system using BIS as the control variable, two proportional-integral-differential control algorithms, a propofol and a remifentanil target-controlled infusion systems as the control actuators. A recent study has shown that such system is able to provide clinically adequate anesthesia. The aim of the present study is to assess the system during rigid bronchoscopy. Two groups of patients are compared: one in which propofol and remifentanil are administered by the anesthesiologist using target-controlled infusion systems, and one in which propofol and remifentanil are administered automatically by the combined closed-loop anesthesia system. In both groups, the goal is to maintain BIS between 40 and 60, the recommended range during anesthesia by the manufacturer. We expect the combined closed-loop anesthesia system group to do similar or better.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- patients undergoing rigid bronchoscopy under general anesthesia
Exclusion Criteria:
- pregnant women
- allergy to propofol or remifentanil
- neurological disorder
- psychotrop treatment
Contacts and Locations
More Information
Publications:
| Responsible Party: | Pr Fischler, Professor of Anesthesiology, Hopital Foch |
| ClinicalTrials.gov Identifier: | NCT00571181 History of Changes |
| Other Study ID Numbers: | 2007/14, EudraCT 2007-003157-82 |
| Study First Received: | December 9, 2007 |
| Last Updated: | April 5, 2009 |
| Health Authority: | France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Keywords provided by Hopital Foch:
|
Algorithms Anesthesia, General/*methods Anesthetics, Intravenous/*administration & dosage Drug Delivery Systems/*methods/statistics & numerical data Electroencephalography/drug effects/*methods/ Feasibility Studies |
Propofol/*administration & dosage Remifentanil/*administration & dosage Bronchoscopy/*methods Prospective Studies Software |
Additional relevant MeSH terms:
|
Anesthetics Propofol Remifentanil Anesthetics, Intravenous Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Central Nervous System Agents |
Therapeutic Uses Anesthetics, General Hypnotics and Sedatives Analgesics, Opioid Analgesics Sensory System Agents Peripheral Nervous System Agents |
ClinicalTrials.gov processed this record on May 23, 2013